Cargando…

Resveratrol Inhibits Cancer Cell Metabolism by Down Regulating Pyruvate Kinase M2 via Inhibition of Mammalian Target of Rapamycin

Metabolism of cancer cells with pyruvate kinase M2 (PKM2) at its centre stage has assumed a prime significance in cancer research in recent times. Cancer cell metabolism, characterized by enhanced glucose uptake, production of lactate and anabolism is considered an ideal target for therapeutic inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iqbal, Mohd Askandar, Bamezai, Rameshwar N. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344940/ https://www.ncbi.nlm.nih.gov/pubmed/22574221 http://dx.doi.org/10.1371/journal.pone.0036764

Ejemplares similares

Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer
por: Prakasam, Gopinath, et al.
Publicado: (2018)

Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition
por: Siddiqui, Farid Ahmad, et al.
Publicado: (2018)

Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2
por: Iqbal, Mohd Askandar, et al.
Publicado: (2013)

In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2
por: Kalaiarasan, Ponnusamy, et al.
Publicado: (2015)

Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy
por: Armour, Sean M., et al.
Publicado: (2009)

Resveratrol Inhibits Inflammatory Responses via the Mammalian Target of Rapamycin Signaling Pathway in Cultured LPS-Stimulated Microglial Cells
por: Zhong, Lian-Mei, et al.
Publicado: (2012)

Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
por: Harder, Jeffrey M., et al.
Publicado: (2020)

Pharmacological Inhibition of ULK1 Kinase Blocks Mammalian Target of Rapamycin (mTOR)-dependent Autophagy
por: Petherick, Katy J., et al.
Publicado: (2015)

Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line
por: SUI, TAO, et al.
Publicado: (2014)

Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?
por: Meyer, Dominique S, et al.
Publicado: (2010)

An engineered photoswitchable mammalian pyruvate kinase
por: Gehrig, Stefanie, et al.
Publicado: (2017)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity
por: Xie, Jianling, et al.
Publicado: (2011)

Knockdown of Pyruvate Kinase M2 Inhibits Cell Proliferation, Metabolism, and Migration in Renal Cell Carcinoma
por: Dey, Prasanta, et al.
Publicado: (2019)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

Disrupting Reconsolidation by Systemic Inhibition of mTOR Kinase via Rapamycin Reduces Cocaine-Seeking Behavior
por: Zhang, Fushen, et al.
Publicado: (2021)

Targeted inhibition of mammalian target of rapamycin (mTOR) enhances radiosensitivity in pancreatic carcinoma cells
por: Dai, Zhi-Jun, et al.
Publicado: (2013)

Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2
por: Shankar Babu, Mani, et al.
Publicado: (2018)

Targeting Endothelial Cell Metabolism by Inhibition of Pyruvate Dehydrogenase Kinase and Glutaminase-1
por: Schoonjans, Céline A., et al.
Publicado: (2020)

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities
por: Tiersma, Jiske F., et al.
Publicado: (2022)

The mammalian target of rapamycin (mTOR) kinase mediates haloperidol-induced cataleptic behavior
por: Ramírez-Jarquín, Uri Nimrod, et al.
Publicado: (2020)

Mammalian target of Rapamycin inhibition and mycobacterial survival are uncoupled in murine macrophages
por: Zullo, Alfred J, et al.
Publicado: (2014)

Inhibiting the Mammalian Target of Rapamycin Blocks the Development of Experimental Cerebral Malaria
por: Gordon, Emile B., et al.
Publicado: (2015)

The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury
por: Campolo, Michela, et al.
Publicado: (2021)

Resveratrol Protects the Myocardium in Sepsis by Activating the Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway and Inhibiting the Nuclear Factor-κB (NF-κB) Signaling Pathway
por: Shang, Xiuling, et al.
Publicado: (2019)

Inhibition of pyruvate dehydrogenase kinase-1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming
por: Xu, Huadan, et al.
Publicado: (2020)

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
por: Javle, Milind M, et al.
Publicado: (2010)

Metastatic perivascular epithelioid cell tumor responding to mammalian target of rapamycin inhibition
por: Ghosh, Indranil, et al.
Publicado: (2014)

Mammalian target of rapamycin inhibition in polycystic kidney disease: From bench to bedside
por: Kim, Hyun-Jung, et al.
Publicado: (2012)

The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors
por: Phan, Alexandria T., et al.
Publicado: (2016)

Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin
por: Wang, Xing, et al.
Publicado: (2017)

TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells
por: Yuan, Peng, et al.
Publicado: (2020)

Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β(1) (TGF-β(1))-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells
por: Cheng, Ke-yan, et al.
Publicado: (2017)

Suppressed “Warburg Effect” in Nasopharyngeal Carcinoma Via the Inhibition of Pyruvate Kinase Type M2-Mediated Energy Generation Pathway
por: Zhao, Penglong, et al.
Publicado: (2020)

Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis
por: Zhan, Cheng, et al.
Publicado: (2015)

Pyruvate kinase M1 regulates butyrate metabolism in cancerous colonocytes
por: Park, Bohye, et al.
Publicado: (2022)

Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer
por: Yamaguchi, Hiroyuki, et al.
Publicado: (2015)

Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma
por: Gasperini, Paola, et al.
Publicado: (2009)

Mammalian target of rapamycin inhibition attenuates myocardial ischaemia–reperfusion injury in hypertrophic heart
por: Ma, Lei‐Lei, et al.
Publicado: (2018)

LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2
por: Lu, Jian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_20pr3eeva5bei7kgcdm8kfh5eq